Global Exosome Therapeutics Market 2024-2028
Global Exosome Therapeutics Market 2024-2028
The exosome therapeutics market is forecasted to grow by USD 234.7 mn during 2023-2028, accelerating at a CAGR of 16.19% during the forecast period. The report on the exosome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, potential of exosomes in personalized medicine, and rising research on exosome therapeutics.
Technavio's exosome therapeutics market is segmented as below:
By Application
- Cancer therapies
- Autoimmune diseases
- Infectious diseases
- Others
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advanced technology in exosome collection as one of the prime reasons driving the exosome therapeutics market growth during the next few years. Also, rising partnerships and collaborations between vendors and healthcare organisations and artificial exosomes for translational nanomedicine will lead to sizable demand in the market.
The report on the exosome therapeutics market covers the following areas:
- Exosome therapeutics market sizing
- Exosome therapeutics market forecast
- Exosome therapeutics market industry analysis
The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading exosome therapeutics market vendors that include Aegle Therapeutics, Aethlon Medical Inc., AMS Biotechnology Europe Ltd., Bio Techne Corp., Capital Biosciences Inc., Capricor Therapeutics Inc., CILOA SAS, Creative Biolabs, Cytiva, Everzom, Evotec SE, Evox Therapeutics Ltd., ExoCoBio Co. Ltd., Inoviq Ltd., Lonza Group Ltd., NanoFCM Co., Ltd, Regeneron Pharmaceuticals Inc., ReNeuron Group PLC, The ExoBiologics Co., and Thermo Fisher Scientific Inc.. Also, the exosome therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.